Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 2,080,000 | 2,277,000 | 2,285,700 | 2,172,400 | 1,672,500 |
| Cost of Goods | 1,043,000 | 1,174,800 | 1,024,000 | 1,001,100 | 949,100 |
| Gross Profit | 1,037,000 | 1,102,600 | 1,261,700 | 1,171,300 | 723,400 |
| Operating Expenses | 591,000 | 615,200 | 538,100 | 496,200 | 418,500 |
| Operating Income | 446,000 | 487,800 | 723,600 | 675,200 | 305,000 |
| Other Income | -28,000 | -108,200 | -28,100 | -84,200 | -1,265,100 |
| Pre-tax Income | 418,000 | 379,600 | 695,500 | 591,000 | -960,100 |
| Income Tax | 75,000 | -76,900 | 87,200 | 96,500 | 48,200 |
| Net Income Continuous | 342,000 | 460,000 | 606,400 | 488,400 | -1,008,700 |
| Net Income | $342,000 | $460,000 | $606,400 | $488,400 | $-1,008,700 |
| EPS Basic Total Ops | 0.45 | 0.60 | 0.79 | 0.64 | -1.40 |
| EPS Basic Continuous Ops | 0.45 | 0.60 | 0.79 | 0.64 | -1.40 |
| EPS Diluted Total Ops | 0.42 | 0.55 | 0.74 | 0.59 | -1.40 |
| EPS Diluted Continuous Ops | 0.41 | 0.55 | 0.73 | 0.59 | -1.40 |
| EBITDA(a) | $583,000 | $918,800 | $723,600 | $675,200 | $305,000 |